Lifecore Biomedical, Inc. (LFCR) Q1 2027 Earnings
Lifecore Biomedical, Inc. reported Q1 2027 revenue of $23.2M, missed analyst consensus of $26.0M by $2.8M. Diluted EPS came in at $-0.43, missed the $-0.29 consensus by $0.14.
Financial Snapshot
Trailing eight quarters through Q1 2027 — latest period from 8-K press release; updates when 10-Q/10-K is filed
Q1 2027 Earnings FAQ
Common questions about Lifecore Biomedical, Inc.'s Q1 2027 earnings report.
Lifecore Biomedical, Inc. (LFCR) reported Q1 2027 earnings on May 6, 2026.
Lifecore Biomedical, Inc. reported revenue of $23.2M and diluted EPS of $-0.43 for Q1 2027.
Revenue missed the consensus estimate of $26.0M by $2.8M. EPS missed the consensus estimate of $-0.29 by $0.14.
You can read the 8-K earnings release (0001005286-26-000018) directly on SEC EDGAR. The filing index links above go to sec.gov.